Jianhong Peng

15PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 27, 2026
Preclinical Pharmacological Evaluation of Sacituzumab Govitecan (IMMU-132) in TROP2-Positive Colorectal Liver Metastasis Models.

|Mar 05, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.

Weihao Li, Jianhong Peng, Jiahua He

|Aug 21, 2025
Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy.

Weili Zhang, Yuxin Gu, Xiajuan Xue

|Jun 30, 2025
circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing NACC1 mRNA stability.

Kai Han, Qiaoqi Sui, Yanbo Xu

|Jun 23, 2025
Neoadjuvant rectal-tumor regression grade combined score as surrogate endpoint for disease-free survival in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy.

Weili Zhang, Hui Sun, Rong Yang

|Jun 19, 2024
Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer.

Jianhong Peng, Weili Zhang, Jiahua He

Pageof 3

Frequent Collaborators

6 joint publications

Weili Zhang

3 joint publications

Weihao Li

2 joint publications

Binyi Xiao

1 joint publications

Ji-Bin Li